We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
CACI
CACI
$10.8B
| $1.39M | ﹤0.01% |
5,320
-503
| -9% | -$142K |
|
|
FFIC
477
DELISTED
Flushing Financial
FFIC
| $1.39M | ﹤0.01% |
71,492
-2,307
| -3% | -$49.2K |
|
478
JD.com
JD
$43.5B
| $1.38M | ﹤0.01% |
80,428
+59,387
| +282% | +$3.52M |
|
479
Henry Schein
HSIC
$9.78B
| $1.37M | ﹤0.01% |
20,798
+418
| +2% | +$31K |
|
480
Harrow
HROW
$1.44B
| $1.35M | ﹤0.01% |
112,040
+2,240
| +2% | +$18.2K |
|
481
Ericsson
ERIC
$32.1B
| $1.34M | ﹤0.01% |
233,845
+42,115
| +22% | +$302K |
|
|
BERY
482
DELISTED
Berry Global Group, Inc.
BERY
| $1.34M | ﹤0.01% |
31,270
+624
| +2% | +$31.3K |
|
|
SCU
483
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $1.32M | ﹤0.01% |
149,615
+43,432
| +41% | +$402K |
|
484
Washington Trust Bancorp
WASH
$748M
| $1.32M | ﹤0.01% |
28,350
-430
| -1% | -$22K |
|
485
Lennar Class A
LEN
$20.4B
| $1.27M | ﹤0.01% |
19,614
+3,014
| +18% | +$234K |
|
486
Knight Transportation
KNX
$11.5B
| $1.27M | ﹤0.01% |
25,874
-3,733
| -13% | -$191K |
|
487
Beazer Homes USA
BZH
$888M
| $1.26M | ﹤0.01% |
130,763
-4,231
| -3% | -$58K |
|
488
Latham Group
SWIM
$660M
| $1.24M | ﹤0.01% |
344,546
+168,840
| +96% | +$964K |
|
|
TCS
489
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $1.24M | ﹤0.01% |
+16,826
| New | +$1.7M |
|
490
Radiant Logistics
RLGT
$400M
| $1.24M | ﹤0.01% |
217,220
+16,857
| +8% | +$119K |
|
491
Green Plains
GPRE
$1.15B
| $1.23M | ﹤0.01% |
71,619
-8,159
| -10% | -$276K |
|
492
Hackett Group
HCKT
$281M
| $1.23M | ﹤0.01% |
69,212
+1,384
| +2% | +$28.1K |
|
493
Scorpio Tankers
STNG
$3.91B
| $1.22M | ﹤0.01% |
29,074
-1,889
| -6% | -$75.2K |
|
494
Quanta Services
PWR
$84.2B
| $1.22M | ﹤0.01% |
9,549
+188
| +2% | +$25.7K |
|
|
QIPT
495
DELISTED
Quipt Home Medical
QIPT
| $1.2M | ﹤0.01% |
288,384
+26,995
| +10% | +$135K |
|
496
Designer Brands
DBI
$315M
| $1.2M | ﹤0.01% |
78,522
-26,303
| -25% | -$412K |
|
497
Bank OZK
OZK
$5.63B
| $1.2M | ﹤0.01% |
30,277
+476
| +2% | +$19.2K |
|
498
UFP Industries
UFPI
$4.95B
| $1.18M | ﹤0.01% |
16,336
+327
| +2% | +$26K |
|
499
Lockheed Martin
LMT
$131B
| $1.18M | ﹤0.01% |
3,041
+60
| +2% | +$25.1K |
|
500
Reinsurance Group of America
RGA
$15.5B
| $1.14M | ﹤0.01% |
9,046
+159
| +2% | +$19.6K |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.